Sebastiano Buti

79PUBLICATIONS
278CO-AUTHORS
Molecular targetsPredictive and prognostic markersSurface water quality processes and contaminated sediment assessmentCancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (79)

|Aug 26, 2026
Molecular biomarkers in metastatic clear cell renal cell carcinoma treated with first-line immune combinations: a systematic review of phase III randomized clinical trials by Meet-URO group.

|Jul 15, 2026
PSMA PET in Lymph Node Staging of Prostate Cancer: From Diagnostic Accuracy to Clinical Decision-Making.

|May 27, 2026
Microplastics as both a driver of genitourinary cancers and a deliverer of treatments.

|Jan 28, 2026
Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial.

Serena Porcari, Chiara Ciccarese, Vitor Heidrich

|Jan 06, 2026
Dissecting the impact of Controlling Nutritional Status (CONUT) score on survival outcomes and immune-inflammatory profiles in patients with advanced NSCLC undergoing first-line immunotherapy.

Federica Pecci, Giulia Mazzaschi, Alessandra Dodi

|Nov 04, 2025
Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study).

Javier Molina-Cerrillo, Giandomenico Roviello, Maria T Bourlon

Pageof 14

Frequent Collaborators

19 joint publications

Melissa Bersanelli

14 joint publications

Sara Elena Rebuzzi

13 joint publications

Giuseppe Luigi Banna

10 joint publications

Ugo De Giorgi